Stay updated on Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Sign up to get notified when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.

Latest updates to the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision log.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding status notice (which referenced the lapse in funding and operating status). Revision: v3.4.1 remains in the history.SummaryDifference0.3%

- Check45 days agoChange DetectedAdministrative site notices (lapse in government funding and Revision: v3.4.1) do not affect the study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedGlossary toggle added and QC metadata label updated to 'Last Update Submitted that Met QC Criteria', with a 'No FEAR Act Data' notice and revision 'v3.4.0' now displayed. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision history updated: added Revision v3.3.4 and removed Revision v3.3.3; this metadata change does not alter the study details, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.